British Prime Minister David Cameron raised GlaxoSmithKline’s (GSK.L) problems in China - where it is being investigated for alleged bribery - with political leaders on Monday as the drugmaker emphasized its commitment to doing business there. Cameron, who is visiting China with executives including GSK chief executive Andrew Witty, discussed the company’s dilemma with China’s leaders and stressed the need for a stable, predictable business environment, a person familiar with the matter said. Witty is part of a 100-strong trade delegation travelling with Cameron.
Help employers find you! Check out all the jobs and post your resume.
